Identification of pre-clinical Alzheimer’s disease by a profile of pathogenic proteins in neurally-derived blood exosomes: a case-control study
By Massimo S. Fiandaca, D. Kapogiannis, M. Mapstone, A. Boxer, E. Eitan, Janice B. Schwartz, E. Abner, Ronald C. Petersen, Howard J. Federoff, Bruce L Miller and 1 more. Alzheimer's & Dementia, 2014
821 citations recorded by the source corpus.
Proteins pathogenic in Alzheimer's disease (AD) were extracted from neurally derived blood exosomes and quantified to develop biomarkers for the staging of sporadic AD.
Subfields: Molecular Biology, Physiology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/d3e42ccd348a5f5f1bc6a92beb693b699997e1f1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
Citations in the corpus
- Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020, result): “of exosome-associated tau are higher in CSF and blood in AD patients compared to controls [252, 253], suggest-”